These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1134602)

  • 21. The need for oncogenetic counselling. Ten years' experience of a regional oncogenetic clinic.
    Henriksson K; Olsson H; Kristoffersson U
    Acta Oncol; 2004; 43(7):637-49. PubMed ID: 15545184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes for patients at risk for inheritable breast cancer: how the nurse practitioner can determine the proper course of action to ensure desired outcomes.
    Fowler MC
    Nurse Pract Forum; 1999 Dec; 10(4):204-7. PubMed ID: 10776261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of familial androgen insensitivity syndrome due to replacement of glutamic acid 802 by lysine.
    Sawai H; Komori S; Sakata K; Nakae K; Shima H; Matsumoto F; Matsumoto H; Onishi Y; Okada Y; Yoshida O; Koyama K
    J Hum Genet; 2000; 45(6):342-5. PubMed ID: 11185742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics in cancer prediction, screening, and counseling: Part II, The nurse's role in genetic counseling.
    Loescher LJ
    Oncol Nurs Forum; 1995 Mar; 22(2 Suppl):16-9. PubMed ID: 7784227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].
    Loman N
    Lakartidningen; 2004 Jun; 101(25):2172-7. PubMed ID: 15281304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Referral to cancer genetic counseling: are there stages of readiness?
    O'Neill SM; Peters JA; Vogel VG; Feingold E; Rubinstein WS
    Am J Med Genet C Semin Med Genet; 2006 Nov; 142C(4):221-31. PubMed ID: 17068804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular studies of a patient with complete androgen insensitivity and a 47,XXY karyotype.
    Girardin CM; Deal C; Lemyre E; Paquette J; Lumbroso R; Beitel LK; Trifiro MA; Van Vliet G
    J Pediatr; 2009 Sep; 155(3):439-43. PubMed ID: 19732585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring family relationships in cancer risk counseling using the genogram.
    Daly M; Farmer J; Harrop-Stein C; Montgomery S; Itzen M; Costalas JW; Rogatko A; Miller S; Balshem A; Gillespie D
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):393-8. PubMed ID: 10207645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foreword.
    Ashley SW
    Curr Probl Surg; 2010 Oct; 47(10):742. PubMed ID: 20816138
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessing hereditary breast cancer risk.
    Cancer Pract; 1999; 7(6):279-84. PubMed ID: 10732524
    [No Abstract]   [Full Text] [Related]  

  • 31. Ethical and legal implications of genetic testing in androgen insensitivity syndrome.
    Berg JS; French SL; McCullough LB; Kleppe S; Sutton VR; Gunn SK; Karaviti LP
    J Pediatr; 2007 Apr; 150(4):434-8. PubMed ID: 17382127
    [No Abstract]   [Full Text] [Related]  

  • 32. Hard choices when breast cancer threatens.
    Mayes JR
    JAAPA; 2001 Mar; 14(3):6, 9. PubMed ID: 11523187
    [No Abstract]   [Full Text] [Related]  

  • 33. [Differential diagnosis and treatment of girls with 46XY-karyotype and androgen insensitivity syndrome].
    Drop SL; Boehmer AL; Slijper FM; Nijman JM; Hazebroek FW; Niermeijer MF
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):665-9. PubMed ID: 11530701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What genetic testing can tell you about breast cancer risk.
    Welch MA
    JAAPA; 2001 Mar; 14(3):50-2, 57-8, 61. PubMed ID: 11523186
    [No Abstract]   [Full Text] [Related]  

  • 35. The genetics of ovarian cancer: concepts in testing and counseling.
    Hartenbach EM; Schink JC
    Curr Opin Obstet Gynecol; 1996 Oct; 8(5):339-42. PubMed ID: 8941429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of familial tumor diseases using genetic counseling and early diagnosis].
    Müller H; Vasen HF
    Schweiz Med Wochenschr; 1990 Oct; 120(40):1451-60. PubMed ID: 1977199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Counseling your patient about heritable breast cancer.
    Thurmon TF
    J La State Med Soc; 1999 Aug; 151(8):421-8. PubMed ID: 10554478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavior genetics: principles, methods and examples from XO, XXY and XYY syndromes.
    Money J
    Semin Psychiatry; 1970 Feb; 2(1):11-29. PubMed ID: 5535861
    [No Abstract]   [Full Text] [Related]  

  • 39. Sex-reversed phenotype in association with two novel mutations c.2494delA and c.T3004C in the ligand-binding domain of the androgen receptor gene.
    Galani A; Sofocleous C; Karahaliou F; Papathanasiou A; Kitsiou-Tzeli S; Kalpini-Mavrou A
    Fertil Steril; 2008 Nov; 90(5):2008.e1-4. PubMed ID: 18342859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Participation in breast cancer risk counseling among women with a family history.
    Bowen D; McTiernan A; Burke W; Powers D; Pruski J; Durfy S; Gralow J; Malone K
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):581-5. PubMed ID: 10428194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.